Literature DB >> 1855016

Relation between nicotine intake and Alzheimer's disease.

C M van Duijn1, A Hofman.   

Abstract

OBJECTIVE: To study the association between Alzheimer's disease and nicotine intake through smoking.
DESIGN: Population based case-control study.
SETTING: City of Rotterdam and four northern provinces of The Netherlands.
SUBJECTS: 198 patients with early onset Alzheimer's disease, 198 controls matched for age and sex, and families of 17 patients in whom Alzheimer's disease was apparently inherited as an autosomal dominant disorder. MAIN OUTCOME MEASURES: Age of onset of dementia, relative risk of Alzheimer's disease.
RESULTS: 89 of 193 patients with Alzheimer's disease had a history of smoking compared with 102 of 195 controls. Among the patients and controls with a family history of dementia, smoking was significantly less common in those with dementia (40/95 with dementia v 55/96 controls; relative risk 0.35; 95% confidence interval 0.16 to 0.78). The risk of Alzheimer's disease decreased with increasing daily number of cigarettes smoked before onset of disease (relative risk 0.3 in those smoking greater than 21/day v 1 in non-smokers). In six families in which the disease was apparently inherited as an autosomal dominant disorder, the mean age of onset was 4.17 years later in smoking patients than in non-smoking patients from the same family (p = 0.03).
CONCLUSIONS: These findings suggest an inverse association between smoking and Alzheimer's disease, although smoking cannot be advocated for other health reasons. We speculate that nicotine may have a role in the aetiology of both Alzheimer's disease and Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855016      PMCID: PMC1670208          DOI: 10.1136/bmj.302.6791.1491

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

1.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

2.  Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

Authors:  S M Ditter; S S Mirra
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

3.  Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

4.  History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease.

Authors:  A Hofman; W Schulte; T A Tanja; C M van Duijn; R Haaxma; A J Lameris; V M Otten; R J Saan
Journal:  Neurology       Date:  1989-12       Impact factor: 9.910

5.  The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type.

Authors:  B Sahakian; G Jones; R Levy; J Gray; D Warburton
Journal:  Br J Psychiatry       Date:  1989-06       Impact factor: 9.319

6.  A case-control study of Alzheimer's disease in Australia.

Authors:  G A Broe; A S Henderson; H Creasey; E McCusker; A E Korten; A F Jorm; W Longley; J C Anthony
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

7.  A case-control study of dementia of the Alzheimer type.

Authors:  L R French; L M Schuman; J A Mortimer; J T Hutton; R A Boatman; B Christians
Journal:  Am J Epidemiol       Date:  1985-03       Impact factor: 4.897

8.  Risk factors for Alzheimer's disease: a case-control study.

Authors:  S L Shalat; B Seltzer; C Pidcock; E L Baker
Journal:  Neurology       Date:  1987-10       Impact factor: 9.910

9.  Smoking and dementia of Alzheimer type.

Authors:  G M Jones; M Reith; M P Philpot; B J Sahakian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

10.  Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: a case control study.

Authors:  L Ferini-Strambi; S Smirne; P Garancini; P Pinto; M Franceschi
Journal:  Neuroepidemiology       Date:  1990       Impact factor: 3.282

View more
  36 in total

1.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Nicotine intake and Alzheimer's disease.

Authors:  R C Pearson; M Mullan; J Hardy; P J Harrison
Journal:  BMJ       Date:  1991-08-10

3.  Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration.

Authors:  S W Rogers; L C Gahring; A C Collins; M Marks
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

4.  Smoking and Alzheimer's disease: an alternative hypothesis.

Authors:  B D Cox; M J Whichelow
Journal:  J Epidemiol Community Health       Date:  1997-10       Impact factor: 3.710

Review 5.  The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.

Authors:  A D Lawrence; B J Sahakian
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 6.  Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment.

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2010-08-24       Impact factor: 2.512

Review 7.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

8.  Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

Authors:  C M van Duijn; L M Havekes; C Van Broeckhoven; P de Knijff; A Hofman
Journal:  BMJ       Date:  1995-03-11

9.  Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.

Authors:  K Ritchie; I Carrière; C W Ritchie; C Berr; S Artero; M-L Ancelin
Journal:  BMJ       Date:  2010-08-05

10.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.